GX CN MEDTECH (02841)
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive...
- Open
- 40.080
- High
- 40.080
- Low
- 40.020
- Prev. Close
- 40.060
- Volume
- 500
- Turnover
- 20.03K
- Avg Price
- 40.064
- Bid/Ask Ratio
- 16.42%
- Amplitude
- 0.15%
- 52wk High
- 54.260
- Volume Ratio
- 0.10
- Turnover Ratio
- 0.17%
News
- AASTOCKS News · 5 hours ago
S&P Global Market Intelligence's Latest Top 10 HK Stocks by Short Selling Ratio
- Simplywall · 20 hours ago
Genscript Biotech (SEHK:1548) Stock Near Doubles As Losses Deepen
- Tip Ranks · 1 day ago, 06:07 AM
Genscript Biotech Clarifies Board Structure and Committee Roles
- Tip Ranks · 1 day ago, 05:37 AM
Genscript Biotech Posts Strong Core Growth but Reports Interim Loss on Legend Impact
- PUBT · 1 day ago, 05:30 AM
GenScript FY26 H1 net loss narrows 28.9% to US$ 129.34 million; revenue rises 27.3% to US$ 404.22 million
- PUBT · Aug 14 at 05:10 AM
Alibaba adjusts exchange price on bonds linked to Alibaba Health shares to HK$ 5.92
